Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes.
about
MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytesRespected Sir(2): magic target for diabetesLow glucose but not galactose enhances oxidative mitochondrial metabolism in C2C12 myoblasts and myotubes.Overexpression of SIRT1 in rat skeletal muscle does not alter glucose induced insulin resistanceHighlights of glycosylation and adhesion related genes involved in myogenesis.The glucose-sensing transcription factor MLX promotes myogenesis via myokine signalingThe influence of high glucose and high insulin on mechanisms controlling cell cycle progression and arrest in mouse C2C12 myoblasts: the comparison with IGF-I effect.Potential role of sirtuins in livestock production.High glucose-mediated alterations of mechanisms important in myogenesis of mouse C2C12 myoblasts.Mechanical stress-activated immune response genes via Sirtuin 1 expression in human periodontal ligament cells.Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C(2)C(12) myotubes.Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway.Glucose concentration and streptomycin alter in vitro muscle function and metabolism.SIRT1 may play a crucial role in overload-induced hypertrophy of skeletal muscle.Adipose tissue, but not skeletal muscle, sirtuin 1 expression is decreased in obesity and related to insulin sensitivity.
P2860
Q28261153-953FE71F-691A-4BBB-8FBA-E9A165DD7BD7Q33697388-AE5C3E57-92FB-430F-853B-2A1D3EDF41BCQ33932159-5C62F46C-47AA-484C-80C7-2CE83E63985EQ34935962-CC4DFD74-B316-4168-854E-24ABB4342A6BQ35208532-95EDD90B-266E-4A17-89BE-F3121AA541BCQ35211154-808999A7-1AD5-40E8-9318-4E5857EFD657Q36406411-21E77825-0AC6-42FD-8990-A3BC04C0DBE4Q37629208-C70868A4-AB9F-4F5C-816D-2750FF7A2A4EQ38048946-905A6D17-FBA1-460A-B2C6-679E525F02D9Q39210519-090823E4-007E-41F7-8594-D2B16D56AB87Q39386719-7DAD874D-ADEE-4ADC-AF65-438D703C5CA0Q39799385-09A0EF44-04EF-41FA-8D1C-CEF681CD2DDFQ44301725-1711179E-4040-4C42-867E-3034174EB788Q46028501-ACEB1E62-1C0C-432B-8EC2-8A7A0B1049B3Q46066885-50EF6CF8-85AE-4604-9CAE-A58C49645FEAQ50126025-69683C2B-8F33-4C73-841C-400616922F77
P2860
Ambient glucose levels qualify the potency of insulin myogenic actions by regulating SIRT1 and FoxO3a in C2C12 myocytes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Ambient glucose levels qualify ...... and FoxO3a in C2C12 myocytes.
@en
type
label
Ambient glucose levels qualify ...... and FoxO3a in C2C12 myocytes.
@en
prefLabel
Ambient glucose levels qualify ...... and FoxO3a in C2C12 myocytes.
@en
P2093
P2860
P1476
Ambient glucose levels qualify ...... 1 and FoxO3a in C2C12 myocytes
@en
P2093
Akito Kadotani
Hideki Katagiri
Miyako Ariga
Taku Nedachi
P2860
P304
P356
10.1152/AJPENDO.00640.2007
P577
2008-01-29T00:00:00Z